Stoke Therapeutics Inc (STOK)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,600,251,000
EV to revenue ratio (TTM)
50.43
EV to ebitda
26.37
Financial Performance
Revenue (TTM)
27,588,000
Gross profit (TTM)
27,588,000
EBITDA
-221,632,992
Profitability
Operating margin (TTM)
-702.00%
Profit margin
0.00%
Return on assets (TTM)
-35.90%
Return on equity (TTM)
-61.10%
Per Share Metrics
Revenue per share (TTM)
0.44
EPS
-3.4
Diluted EPS (TTM)
-3.4
Book value
5.54
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
204.08
PEG ratio
Price to sales ratio (TTM)
58.01
Price to book ratio (TTM)
4.868
Growth
Quarterly earnings growth (YoY)
-32.50%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
12
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.233